Who owns PowerShares Dynamic Biotech &Genome;?

Key details on PowerShares Dynamic Biotech &Genome; (Ticker: PBE)

Who owns PowerShares Dynamic Biotech &Genome;?

Is PBE a good stock to own? Find out who bought PowerShares Dynamic Biotech &Genome;, who sold PowerShares Dynamic Biotech &Genome; (PBE) stock, and who holds a large position in PowerShares Dynamic Biotech &Genome;.

Fund Name Number of Shares Share Valuation As Of
MORGAN STANLEY 393881 $21.10M Dec. 31, 2015
UBS AG 348011 $16.09M Sept. 30, 2014
UBS Group AG 248140 $12.54M Dec. 31, 2015
Bank of America Corporation 236522 $11.95M Dec. 31, 2015
LPL Financial 179376 $8.68M Dec. 31, 2015
Trillium Asset Management Corporation 137735 $5.27M March 31, 2016
Quantitative Advantage 123705 $6.25M Dec. 31, 2015
SUSQUEHANNA INTERNATIONAL 106779 $4.45M March 31, 2014
JANE STREET 103071 $4.29M March 31, 2014
Gerber Kawasaki Wealth & Investment Management 99098 $5.01M Dec. 31, 2015
Wells Fargo & Company 96969 $4.91M Dec. 31, 2015
HighTower Advisors 87700 $5.27M June 30, 2015
Royal Bank of Canada 67996 $3.14M Sept. 30, 2014
GOLDMAN SACHS 66292 $3.35M Dec. 31, 2015
KCG Holdings 63091 $2.63M March 31, 2014
Name SignalPoint Asset Management 57570 $2.63M Sept. 30, 2015
PACIFIC FINANCIAL 56652 $1.99M Sept. 30, 2013
Traynor Capital Management 55444 $2.12M March 31, 2016
HILLS BANK AND TRUST COMPANY 55358 $2.53M Sept. 30, 2015

Who sold PowerShares Dynamic Biotech &Genome;?

Fund Name Date Sold Number of Shares Sold Share Valuation
Niemann Capital Management March 31, 2014 98154 $4.09M
Janney Montgomery Scott Sept. 30, 2011 77276 $1.41M
Chatham Capital June 30, 2011 61385 $1.38M
Credit Suisse AG June 30, 2011 57076 $1.28M
Hays Advisory Dec. 31, 2010 60887 $1.33M